Physician profile
Johnathan Stephan
NPI 1558942268
$1,459.20
in general payments reported to CMS, 2019-2025
14 companies · $1,190 in 2025
The $1,190 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $269 · 2025: $1,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,130 · Education: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,130.10 |
| Education | $329.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $313.33 | 2025 | Cleviprex, Kengreal |
| Abbott Laboratories | $236.87 | 2024 | Ensite |
| Kestra Medical Technology Services, INC. | $218.01 | 2025 | Assure Wcd |
| Stryker Corporation | $150.00 | 2025 | Artix Mt |
| Bayer Healthcare Pharmaceuticals INC. | $142.90 | 2025 | |
| Amgen INC. | $110.50 | 2025 | Repatha |
| Atricure, INC. | $88.69 | 2025 | Atriclip Laa Exclusion System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.08 | 2025 | Jardiance |
| Abiomed | $35.36 | 2025 | |
| Novartis Pharmaceuticals Corporation | $32.89 | 2025 | |
| Pfizer INC. | $31.90 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $22.47 | 2025 | Opsumit |
| Astrazeneca Pharmaceuticals LP | $20.71 | 2025 | Wainua |
| Inspiremd LTD | $14.49 | 2025 | Cguard Prime Carotid Stent System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnathan Stephan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.